These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Other 2018-001991-39 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients with Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF) Sperimentazione random... not-yet-due
Ongoing 2022-001816-25 A Phase 2 trial of Nirogacestat in Patients with Recurrent Ovarian Granulosa Cell Tumors not-yet-due